Skip to main content

Table 2 Correlations between preoperative SII and clinicopathological characteristics in primary and validation cohort

From: Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer

Clinical parameter

Primary Cohort

Validation Cohort

MPV/PC ≤ 0.41 (141)

MPV/PC>0.41 (142)

χ2

P

MPV/PC ≤ 0.41 (55)

MPV/PC>0.41(70)

χ2

P

Age

  

0.09

0.768

  

1.40

0.237

  ≤ 45

69

67

  

24

38

  

  > 45

72

75

  

31

32

  

Histological grade

  

0.33

0.850

  

0.30

0.860

 G1

12

10

  

5

7

  

 G2

74

73

  

31

36

  

 G3

55

59

  

19

27

  

Tumor invasion depth

  

0.78

0.376

  

0.01

0.907

  ≤ 1/2

106

113

  

32

40

  

  > 1/2

35

29

  

23

30

  

Tumor size

  

0.01

0.957

  

1.48

0.223

  ≤ 4

77

78

  

27

42

  

  > 4

64

64

  

28

28

  

Lymphovascular invasion

  

0.12

0.734

  

2.81

0.094

 No

115

118

  

34

53

  

 Yes

26

24

  

21

17

  

FIGO stage

  

3.51

0.173

  

0.58

0.749

 IA

39

26

  

14

17

  

 IB

78

88

  

24

35

  

 IIA

24

28

  

17

18

  

Radiotherapy

  

2.71

0.099

  

0.32

0.574

 No

125

116

  

41

49

  

 Yes

16

26

  

14

21

  

NLR

  

0.18

0.674

  

1.73

0.189

 NLR ≤ 2.75

77

74

  

18

31

  

 NLR > 2.75

64

68

  

37

39

  

PLR

  

7.26

0.007*

  

17.96

< 0.001*

 PLR ≤ 128

52

75

  

21

53

  

 PLR > 128

89

67

  

34

17

  

MLR

  

1.36

0.243

  

0.54

0.462

 MLR ≤ 0.27

90

81

  

28

31

  

 MLR > 0.27

51

61

  

27

39

  
  1. MPV/PC mean platelet volume/platelet count, NLR neutrophil lymphocyte ratio, PLR platelet lymphocyte ratio, MLR monocyte lymphocyte ratio
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us